Evidence map›Paper›PMID 30582812›Full record

ArticleAnalytical chemistry2019

Metabolomic Studies of Live Single Cancer Stem Cells Using Mass Spectrometry.

Mei Sun, Zhibo Yang

Abstract read
In one paragraph

Article in Analytical chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed.

  1. The metabolic profiles of cancer stem cells.Stem cell research & therapy · 2026
    Review
  2. Metabolic reprogramming and plasticity of cancer stem cells.Frontiers in cell and developmental biology · 2026
    Review
  3. Metabolomics of healthy hematopoietic stem cells and leukemic stem cells.Journal of clinical and translational research · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Targeting Lipid Metabolism in Cancer Stem Cells for Anticancer Treatment.International journal of molecular sciences · 2024
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. The role of metabolism in cellular quiescence.Journal of cell science · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mei SunDepartment of Chemistry and Biochemistry , University of Oklahoma , Norman , Oklahoma 73019 , United States.
Zhibo YangDepartment of Chemistry and Biochemistry , University of Oklahoma , Norman , Oklahoma 73019 , United States.ORCID 0000-0003-0370-7450

Funding

From Single Cells to Tissues: a Novel Mass Spectrometry Approach for BioanalysisR01GM116116 · NIGMS · UNIVERSITY OF OKLAHOMA · PI YANG, ZHIBO · 2015 to 2019
$1.5M
Mass Spectrometry Detection of Drugs in Single Bladder Cancer Cells from PatientsR21CA204706 · NCI · UNIVERSITY OF OKLAHOMA · PI BURGETT, ANTHONY WG · 2016 to 2018
$599k
NCI NIH HHS R21 CA204706NIGMS NIH HHS R01 GM116116
6 · The paper itself

Abstract

Cancer stem cells (CSCs) are rare types of cells responsible for tumor development, relapse, and metastasis. However, current research in CSC biology is largely limited by the difficulty of obtaining sufficient CSCs. Single-cell analysis techniques are promising tools for CSC-related studies. Here, we used the Single-probe mass spectrometry (MS) technique to investigate the metabolic features of live colorectal CSCs at the single-cell level. Experimental data were analyzed using statistical analysis methods, including the t-test and partial least squares discriminant analysis. Our results indicate that the overall metabolic profiles of CSCs are distinct from non-stem cancer cells (NSCCs). Specifically, we demonstrated that tricarboxylic acid (TCA) cycle metabolites are more abundant in CSCs compared to NSCCs, indicating their major energy production pathways are different. Moreover, CSCs have relatively higher levels of unsaturated lipids. Inhibiting the activities of stearoyl-CoA desaturase-1 (SCD1), nuclear factor κB (NF-κB), and aldehyde dehydrogenases (ALDH1A1) in CSCs significantly reduced the abundances of unsaturated lipids and hindered the formation of spheroids, resulting in reduced stemness of CSCs. Our techniques and experimental protocols can be potentially used for metabolomic studies of other CSCs and rare types of cells and provide a new approach to discovering functional biomarkers as therapeutic targets.

Indexed as

MetabolomeAldehyde Dehydrogenase 1 FamilyCitric Acid CycleDiscriminant AnalysisEnzyme InhibitorsFatty Acids, UnsaturatedHCT116 CellsHumansLeast-Squares AnalysisMass SpectrometryMetabolomicsNeoplastic Stem CellsNF-kappa B p50 SubunitRetinal DehydrogenaseSesquiterpenesSingle-Cell AnalysisAldehyde Dehydrogenase 1 FamilyALDH1A1 protein, humanEnzyme InhibitorsFatty Acids, UnsaturatedLC-1 compoundNF-kappa B p50 SubunitNFKB1 protein, humanRetinal DehydrogenaseSCD1 protein, humanSesquiterpenesStearoyl-CoA Desaturase

Identifiers

PMID30582812
PMCPMC6582952

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.